2010
DOI: 10.1186/1746-6148-6-57
|View full text |Cite
|
Sign up to set email alerts
|

Impact of antigenic and genetic drift on the serologic surveillance of H5N2 avian influenza viruses

Abstract: BackgroundSerologic surveillance of Avian Influenza (AI) viruses is carried out by the hemagglutination inhibition (HI) test using reference reagents. This method is recommended by animal health organizations as a standard test to detect antigenic differences (subtypes) between circulating influenza virus, vaccine- and/or reference- strains. However, significant discrepancies between reference antisera and field isolates have been observed during serosurveillance of influenza A viruses in pig and poultry farms… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
21
0
1

Year Published

2012
2012
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(22 citation statements)
references
References 27 publications
0
21
0
1
Order By: Relevance
“…Failure to regularly update antigens in HI-assay can result in a reduced ability to detect antibodies against more recent field isolates [27] and it is unclear if this also can be observed in our assay system. The strains used for the infections of group 2 animals were closely related to the strains from which antigens were produced, with the lowest level of AA-identity for antigen H9.07 (94.4%) (Table 3).…”
Section: Discussionmentioning
confidence: 99%
“…Failure to regularly update antigens in HI-assay can result in a reduced ability to detect antibodies against more recent field isolates [27] and it is unclear if this also can be observed in our assay system. The strains used for the infections of group 2 animals were closely related to the strains from which antigens were produced, with the lowest level of AA-identity for antigen H9.07 (94.4%) (Table 3).…”
Section: Discussionmentioning
confidence: 99%
“…The impact of vaccination on virus evolution has been observed during H5N2 outbreaks in Mexico, where 2 billion doses of vaccine were administered from 1995–2008 (Eggert et al, 2010). Despite this vaccination program LPAI H5N2 viruses have continued to circulate in Mexico for almost 20 years, with spread to neighboring countries (Escorcia et al, 2010; Lee et al, 2004). It is thought that the long-term use of H5N2 vaccines in poultry has led to antigenic drift and diversification of LPAI H5N2 viruses away from the vaccine strain, with challenge experiments showing that the vaccine was unable to prevent shedding of LPAI H5N2 virus (Escorcia et al, 2010; Lee et al, 2004).…”
Section: Vaccinationmentioning
confidence: 99%
“…Despite this vaccination program LPAI H5N2 viruses have continued to circulate in Mexico for almost 20 years, with spread to neighboring countries (Escorcia et al, 2010; Lee et al, 2004). It is thought that the long-term use of H5N2 vaccines in poultry has led to antigenic drift and diversification of LPAI H5N2 viruses away from the vaccine strain, with challenge experiments showing that the vaccine was unable to prevent shedding of LPAI H5N2 virus (Escorcia et al, 2010; Lee et al, 2004). There are therefore striking parallels with the HPAI H5N1 situation, and it is therefore possible that the large-scale vaccination programs in China, Egypt and Indonesia may have contributed to the antigenic drift of circulating viruses.…”
Section: Vaccinationmentioning
confidence: 99%
“…While the former test specifically detects antibodies directed against epitopes of the haemagglutinin neuraminidase protein of APMV-1, the ELISA detects mostly a wider spectrum of antibodies specific for different viral proteins , unless designed to detect specific antibodies against a selected structural protein. Furthermore, it has been observed, in avian influenza diagnosis, that the performance of HI test is strongly influenced by the homology or relatedness between the reference viral antigens and the virus isolate or antibodies to be tested (Escorcia et al, 2010) and this may be equally valid for NDV. Blocking antibodies developed against the PMV-1 epitope, like the one used in the bELISA, are specific for the NDV infection in any host and at any age (Koch et al, 1998).…”
Section: Discussionmentioning
confidence: 99%